UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Leukemia, 2013-06, Vol.27 (6), p.1322-1327

2013

Volltextzugriff (PDF)

P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004‐2017

HemaSphere, 2022-06, Vol.6, p.670-671

2022

Volltextzugriff (PDF)

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response

Blood cancer journal (New York), 2022-01, Vol.12 (1), p.7-8, Article 7

2022

Volltextzugriff (PDF)

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3"

Blood cancer journal (New York), 2022-04, Vol.12 (4), p.55-55, Article 55

2022

Volltextzugriff (PDF)

P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT‐NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS

HemaSphere, 2022-06, Vol.6, p.443-444

2022

Volltextzugriff (PDF)

P1094: CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF PATIENTS WITH T‐CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AT A LARGE TERTIARY CARE CENTER

HemaSphere, 2022-06, Vol.6 (Suppl), p.984-985

2022

Volltextzugriff (PDF)

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

Blood cancer journal (New York), 2017-03, Vol.7 (3), p.e550-e550

2017

Volltextzugriff (PDF)

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

Blood cancer journal (New York), 2016-04, Vol.6 (4), p.e414-e414

2016

Volltextzugriff (PDF)

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Leukemia, 2013-07, Vol.27 (7), p.1504-1510

2013

Volltextzugriff (PDF)

Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia

Journal of clinical pharmacy and therapeutics, 2009-10, Vol.34 (5), p.607-610

2009

Volltextzugriff (PDF)

Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells

Leukemia, 2017-06, Vol.31 (6), p.1434-1442

2017

Volltextzugriff (PDF)

A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target

Leukemia, 2018-04, Vol.32 (4), p.865-873

2018

Volltextzugriff (PDF)

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

Blood cancer journal (New York), 2017-08, Vol.7 (8), p.e592-e592

2017

Volltextzugriff (PDF)

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Blood cancer journal (New York), 2017-09, Vol.7 (9), p.e607-e607

2017

Volltextzugriff (PDF)

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

Leukemia, 2015-03, Vol.29 (3), p.741-744

2015

Volltextzugriff (PDF)

Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults

Leukemia, 2016-05, Vol.30 (5), p.1177-1180

2016

Volltextzugriff (PDF)

Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

Leukemia, 2015-02, Vol.29 (2), p.498-500

2015

Volltextzugriff (PDF)

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Volltextzugriff (PDF)

The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia - A Single Center Retrospective Study

Blood and lymphatic cancer, 2021-01, Vol.11, p.1-9

2021

Volltextzugriff (PDF)

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Blood cancer journal (New York), 2016-03, Vol.6 (3), p.e405-e405

2016

Volltextzugriff (PDF)

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Leukemia, 2013-10, Vol.27 (10), p.2112

2013

Volltextzugriff (PDF)

IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes

Leukemia, 2012-04, Vol.26 (4), p.693-699

2012

Volltextzugriff (PDF)

88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?

Leukemia research, 2015-04, Vol.39, p.S44-S45

2015

Volltextzugriff (PDF)

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

Blood cancer journal (New York), 2013-07, Vol.3 (7), p.e122-e122

2013

Volltextzugriff (PDF)

1 – 25 von 523

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(495)
Mit Volltextzugriff
(462)

Publikationsform

Sprache

Englisch
(523)

Erscheinungsjahr

n.n

Thema

Science & Technology
(212)
Life Sciences & Biomedicine
(205)
Hematology
(170)
Humans
(161)
Oncology
(98)
Male
(92)
Aged
(85)
Female
(85)
Middle Aged
(83)
Adult
(62)
Mutation
(57)
Aged, 80 And Over
(53)
Leukemia
(53)
Prognosis
(46)
Retrospective Studies
(38)
Acute Myeloid Leukemia
(35)
Myelodysplastic Syndromes
(33)
Myelodysplastic Syndrome
(30)
Leukemia, Myeloid, Acute - Genetics
(29)
Young Adult
(28)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(435)
Publisher website
(265)
Ovid
(176)
MEDLINE
(162)
Wiley-Blackwell Journals
(72)
Wiley Online Library
(71)
Ingenta
(65)
Nature
(56)
Access via ScienceDirect (Elsevier)
(47)
IngentaConnect Journals
(30)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(29)
Nexis Uni
(18)
Access via Taylor & Francis
(17)
Taylor & Francis
(14)
Taylor & Francis Online
(13)
Springer Journals
(10)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(8)
IEEE Xplore
(5)
Springer Book Series
(3)
Access via Oxford University Press
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(184)
American Journal Of Hematology
(41)
Journal Of Clinical Oncology
(38)
Blood Cancer Journal
(33)
Haematologica
(17)
Leukemia Research
(17)
Clinical Lymphoma, Myeloma And Leukemia
(16)
British Journal Of Haematology
(15)
Leukemia
(15)
Hemasphere
(13)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004‐2017

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3"

P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT‐NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS

P1094: CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF PATIENTS WITH T‐CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AT A LARGE TERTIARY CARE CENTER

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO‐MYELOID CLINICAL TRIAL PROGRAM

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia

Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells

A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults

Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia - A Single Center Retrospective Study

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes

88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

Suchergebnisse filtern